What we do
Stemina is the world leader in building human cellular models for toxicity screening of drug candidates, chemical compounds, cosmetic and tobacco ingredients. Our developmental toxicity assays are the only human system for assessing the risk that a compound will cause birth defects if a woman is exposed during pregnancy.

What we do


Stemina's toxicology assays are the only human in vitro assays for developmental toxicity screening.



Stemina's metabolomics platform and expertise in cellular models can be used for custom projects.


Our Team

Stemina has assembled a world class team of scientists and experts. Meet our team.


Latest news

Feb 20

Stemina to Present Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2017

Feb 20, 2017
Stemina Biomarker Discovery will be well represented at the Society of Toxicology’s 56th Annual Meeting and ToxExpo. In addition to participating in SOT as an exhibitor (booth 2506), Stemina’s Jessica Palmer, Associate Director of Toxicology, will present new research in two sessions: Poster session: Monday, March 13th | 9:30 AM – 12:45 PM | P331

Read more
Feb 9

NeuroPointDX Partners with Ovid Therapeutics to Identify Biomarkers for Angelman Syndrome

Feb 9, 2017
Together, Ovid and NeuroPointDX will use metabolomics data to better understand the rare neuro-genetic disorder known as Angelman Syndrome. NeuroPointDX’s metabolomics technology will be used in Ovid’s phase 2 STARS trial of its drug candidate, OV101. Read more

Read more
Jan 18

Stemina Hosts Webinar: Exposure-Based Developmental Toxicity Prediction with the devTOX quickPredict Assay

Jan 18, 2017
The required in vivo preclinical models for developmental toxicity testing have varying degrees of concordance with human effects, having approximately 70% concordance to known human developmental toxins. Development and validation of alternative methods for assessing developmental toxicity potential, such as the devTOX quickPredict assay (devTOXqP) would decrease the time, expense, and use of vertebrate animals.

Read more